Twenty-five out of the 33 patients with KIT/PDGFRA-mutated GIST at diagnosis underwent at least one line of systemic treatment with imatinib, sunitinib—or both —before surgery. This evidence concerns the gene KIT and gastrointestinal stromal tumor.